Literature DB >> 29345579

Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma.

Fatima Ardito1, Giovanni Di Gioia1, Mario Roberto Pellegrino1, Lorenzo Lo Muzio1.   

Abstract

The use of nutraceuticals as protection drugs against chronic diseases gained a vast success. Many studies found that nutraceuticals may reduce the tumorigenic actions of carcinogens, inhibiting the adhesion and proliferation of tumor cells. Genistein is a natural isoflavone preventing osteoporosis, menopause problems and heart diseases. It is also known in China and Japan for its anticancer properties. The available treatment protocols for Head and neck squamous cell cancer (HNSCC) have led to poor results and new therapies are necessary. In this paper, we will review anticancer therapeutic potential of genistein and in vitro and in vivo studies that suggest its potential role in the treatments of HNSCC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Genistein; HNSCC; Isoflavone; Nutraceuticals; OSCC; Therapy.

Mesh:

Substances:

Year:  2018        PMID: 29345579     DOI: 10.2174/1568026618666180116122650

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

1.  Genistein anticancer efficacy during induced oral squamous cell carcinoma: an experimental study.

Authors:  Ahmed M Hussein; Abdelraheim H Attaai; Asmaa M Zahran
Journal:  J Egypt Natl Canc Inst       Date:  2022-09-05

2.  Induction of G2/M Cell Cycle Arrest and Apoptosis by Genistein in Human Bladder Cancer T24 Cells through Inhibition of the ROS-Dependent PI3k/Akt Signal Transduction Pathway.

Authors:  Cheol Park; Hee-Jae Cha; Hyesook Lee; Hyun Hwang-Bo; Seon Yeong Ji; Min Yeong Kim; Su Hyun Hong; Jin-Woo Jeong; Min Ho Han; Sung Hyun Choi; Cheng-Yun Jin; Gi-Young Kim; Yung Hyun Choi
Journal:  Antioxidants (Basel)       Date:  2019-08-21

Review 3.  Genistein: A Review on its Anti-Inflammatory Properties.

Authors:  Yu Xian Goh; Juriyati Jalil; Kok Wai Lam; Khairana Husain; Chandini Menon Premakumar
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

Review 4.  Can genistein be a potential agent against skin side effects associated with the treatment of breast cancer?

Authors:  Magda A Pawlicka; Agata Filip
Journal:  Postepy Dermatol Alergol       Date:  2022-02-28       Impact factor: 1.837

Review 5.  Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause.

Authors:  Valentina Echeverria; Florencia Echeverria; George E Barreto; Javier Echeverría; Cristhian Mendoza
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

Review 6.  Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances.

Authors:  Hardeep Singh Tuli; Muobarak Jaber Tuorkey; Falak Thakral; Katrin Sak; Manoj Kumar; Anil Kumar Sharma; Uttam Sharma; Aklank Jain; Vaishali Aggarwal; Anupam Bishayee
Journal:  Front Pharmacol       Date:  2019-12-06       Impact factor: 5.810

7.  lncRNA TSPEAR-AS2, a Novel Prognostic Biomarker, Promotes Oral Squamous Cell Carcinoma Progression by Upregulating PPM1A via Sponging miR-487a-3p.

Authors:  Yi-Chao Xia; Jun Cao; Jing Yang; Ying Zhang; Yong-Sheng Li
Journal:  Dis Markers       Date:  2021-07-17       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.